Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

Schedule of Concentration of Risk, by Risk Factor

The table sets forth the percentage of sales attributable to each customer during the periods presented, and the respective customer’s ending accounts receivable balance as a percentage of reported accounts receivable, net, as of March 31, 2018 and 2017.

	Three Months Ended March 31, 2018			As of  March 31, 2018			Three Months Ended  March 31, 2017			As of  March 31, 2017
Customer	Sales			Accounts Receivable			Sales			Accounts Receivable
Centric		14.2	%		21.8	%		7.2	%		26.2	%
Elosoft		4.2	%		11.1	%		9.4	%		7.0	%
IDS		14.8	%		0.0	%		9.8	%		0.0	%
Uniface		1.8	%		1.0	%		4.6	%		14.5	%
Raytheon		3.3	%		10.6	%		10.0	%		0.0	%
Thermo Lab Systems		6.8	%		22.4	%		6.3	%		19.2	%
Total		45.1	%		66.9	%		47.3	%		66.9	%

Schedule of Revenue

The cumulative effect of the changes made to our condensed consolidated balance sheet as of January 1, 2018 under current assets, deferred revenue and accumulated deficit for the adoption ASU 2014-09, Revenue - Revenue from Contracts with Customers were as follows:

Balance Sheet	Balance at December 31, 2017			Adjustments due to ASC 606			Balance at January 1, 2018
Current Assets
Deferred COGS	$	—		$	20,000		$	20,000
Liabilities and Stockholders’ Equity
Accumulated Deficit	$	(81,849,200	)	$	1,391,900		$	(80,457,300	)
Current Liabilities
Deferred Revenue	$	1,845,100		$	(609,700	)	$	1,235,400
Long Term Liabilities
Deferred Revenue	$	1,409,700		$	(802,200	)	$	607,500